Expert Perspectives 2024: Nonsteroidal Topicals for Atopic Dermatitis with Mona Shahriari, MD

In this Patient Care© year-end video series we feature interviews with leading physician scientists and principal investigators who discuss the most important clinical trials of the year with experimental drugs, devices, and procedures, the implications of findings for daily primary care practice, and the promise of these unique additions to patient care.

Welcome to Expert Perspectives 2024: Interviews with Key Opinion Leaders on Novel Therapeutics

In the interview series that begins with the video above, Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University School of Medicine in New Haven, CT and co-founder of Central Connecticut Dermatology in Cromwell, CT discusses the shift toward understanding atopic dermatitis as a disease spectrum that "is much more complex than once thought." No longer considered a disease of childhood that will be outgrown, the burden of atopic dermatitis across the lifespan is considerable. Shahriari highlights the importance of primary care in managing the condition, noting they remain the first clinicians a patient will consult. She also details the mechanisms of action for the newest classes of nonsteroidal topical treatments and considers patient selection.

In the first segment Atopic Dermatitis is Not "Just" Eczema: Disease Primer with Mona Shahriari, MD, (above) she provides a brief overview of the inflammatory skin disease for primary care clinicians.

For the other videos in the series, please see:

Dermatologist Mona Shahriari, MD, Talks Nonsteroidal Topicals for Atopic Dermatitis

There are 3 classes of nonsteroidal topical therapies for atopic dermatitis that target the specific underlying pathophysiology of the skin disease. Shahriari provides a primer.

Topical Steroids Still Have a Role in Atopic Dermatitis Treatment, But It is Limited Expert Says

Topical corticosteroids, once revolutionary for treatment of atopic dermatitis, are used just sparingly today; dermatologist Mona Shahriari, MD, lists the reasons.

Dermatologist Mona Shahriari, MD, Relies on Primary Care Colleagues as First-Line Prescribers for AD

Not all atopic dermatitis requires treatment by a specialist, says this dermatologist, and she collaborates regularly with her primary care colleagues.

Why is Atopic Dermatitis Prevalence Rising? Dermatologist Mona Shahriari, MD, Parses the Trends

Shahriari, assistant clinical professor of dermatology at Yale University School of Medicine, says greater understanding of the condition has expanded the population for the diagnosis.